Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £239.60m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Trading and Board Update

12 Jul 2021 07:00

RNS Number : 8030E
Science Group PLC
12 July 2021
 

 

 

 

 

12 July 2021

 

Trading and Board Update

 

 

Science Group plc (the "Company") together with its subsidiaries ("Science Group" or the "Group") provides the following trading update.

 

As reported at the time of the AGM on 19 May 2021, all three divisions of the Group had a good start to the year. This momentum has continued throughout the first half and the Board now anticipates that, for the 6 months to 30 June 2021, the Group will report revenue in excess of £40 million and adjusted operating profit ("AOP") in excess of £7 million. This is an excellent performance, ahead of the upgraded expectations at the time of the AGM and an AOP increase of over 40% relative to the prior year, despite significant currency exchange headwinds.

 

The interim results are anticipated to be released in the last week of July.

 

Board Change

 

By mutual agreement, Mr Sameet Vohra, Chief Financial Officer, will be resigning from the Board at the end of July and will leave the Group at the end of September. Mr Vohra joined the Company in January and his appointment became effective in late April.

 

Science Group's success is derived from its integrated organisation, with a hands-on operating management culture at all levels of the Group. After a career in significantly larger companies, it has become apparent that the role within Science Group is not aligned with Mr Vohra's aspirations.

 

Mr Jon Brett, currently Group Financial Controller, will be appointed Acting Group Finance Director upon satisfactory completion of the necessary AIM Rules and other compliance procedures at which point it is envisaged that Mr Brett will be appointed to the Board. Mr Brett trained with Deloitte LLP and qualified in 2004. He joined Science Group in March 2020.

 

 

End

 

Science Group plc Tel : +44 (0) 1223 875200

Martyn Ratcliffe, Chairman www.sciencegroup.com

 

 

Stifel Nicolaus Europe Limited (Nominated Adviser & Broker) Tel : +44 (0) 20 7710 7600

Nick Adams, Alex Price

 

 

Liberum Capital Limited (Joint Broker) Tel: +44 (0) 20 3100 2000

Neil Patel, Cameron Duncan

 

This announcement contains inside information. The person responsible for this announcement is Martyn Ratcliffe.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKUORAWUBRAR
Date   Source Headline
11th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:01 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTreasury shares issued
1st Jun 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:01 amRNSTransaction in Own Shares
27th May 20267:00 amRNSIssue of share options and PDMR dealing
22nd May 20267:00 amRNSTreasury Shares Issued
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20261:05 pmRNSResult of Annual General Meeting
20th May 20267:01 amRNSAGM Trading Update and Capital Allocation
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:01 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTreasury Shares Issued
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:01 amRNSNotice of Annual General Meeting
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTreasury Shares Issued
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.